0001209191-16-156176.txt : 20161220
0001209191-16-156176.hdr.sgml : 20161220
20161220185022
ACCESSION NUMBER: 0001209191-16-156176
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161218
FILED AS OF DATE: 20161220
DATE AS OF CHANGE: 20161220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SUITE 400, 101 LINDENWOOD DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-321-5554
MAIL ADDRESS:
STREET 1: SUITE 400, 101 LINDENWOOD DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ali-Jackson Kamil
CENTRAL INDEX KEY: 0001654337
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 162062436
MAIL ADDRESS:
STREET 1: C/O ACLARIS THERAPEUTICS, INC.
STREET 2: 101 LINDENWOOD DRIVE, SUITE 400
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-12-18
0
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001654337
Ali-Jackson Kamil
C/O ACLARIS THERAPEUTICS, INC.
101 LINDENWOOD DRIVE, SUITE 400
MALVERN
PA
19355
0
1
0
0
Chief Legal Officer
Common Stock
2016-12-18
4
M
0
1075
A
77032
D
Common Stock
2016-12-18
4
F
0
327
31.25
D
76705
D
Restricted Stock Units
2016-12-18
4
M
0
1075
0.00
D
Common Stock
1075
3225
D
Restricted stock units convert into common stock on a one-for-one basis.
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.
On December 18, 2015, the reporting person was granted 4,300 restricted stock units, vesting in four equal annual installments beginning on December 18, 2016, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.
/s/ Brian F. Leaf, Attorney-in-fact
2016-12-20